ABL-BCR expression in BCR-ABL-positive human leukemia cell lines

Leukemia Research

Volumn 23, Issue 11, 1999, Pages 1055-1060

  Uphoff, Cord C ^a   Habig, Silke ^a   Fombonne, Séverine ^a   Matsuo, Yoshinobu ^b   Drexler, Hans G ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^b Fujisaki Cell Center   (Japan)

Author keywords

bcr; ABL; Cell lines; m bcr; M bcr; Philadelphia chromosome

Indexed keywords

ARTICLE; CELL LINE; GENE EXPRESSION; GENE FUSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

BASE SEQUENCE; DNA PRIMERS; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032830127     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00131-9     Document Type: Article

References (18)

1. Melo J.V. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 88:1996;2375-2384.
2. Vickers M. Estimation of the number of mutations necessary to cause chronic myeloid leukaemia from epidemiological data. Br. J. Haematol. 94:1996;1-4.
3. Melo J.V. The molecular biology of chronic myeloid leukaemia. Leukemia. 10:1996;751-756.
4. Pane F., Frigeri F., Sinodna M., Luciano L., Ferrara F., Cimino R., Meloni G., Saglio G., Salvatore F., Rotoli B. Neutrophilic chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood. 88:1996;2410-2414.
5. Gotoh A., Broxmeyer H.E. The function of BCR/ABL and related proto-oncogenes. Curr. Opinion. Hematol. 4:1997;3-11.
6. Melo J.V., Gordon D.E., Cross N.C.P., Goldman J.M. The ABL-BCR fusion gene is expressed in chronic myeloid leukemia. Blood. 81:1993;158-165.
7. MacKenzie E., Stewart E., Birnie G.D. ABL-BCR mRNAs transcribed from chromosome 9q+ in Philadelphia-chromosome-positive chronic myeloid leukaemia. Leukemia. 7:1993;702-706.
8. Melo J.V., Hochhaus A., Yan X.H., Goldman J.M. Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemia. Br. J. Haemat. 92:1996;684-686.
9. Drexler HG, Dirks W, MacLeod RAF, Quentmeier H, Steube K., Uphoff CC, DSMZ Catalogue of Human and Animal Cell Lines, 7th ed. Braunschweig, Germany:DSMZ, 1999.
10. Drexler H.G., MacLeod R.A.F., Uphoff C.C. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia. Leuk. Res. 23:1999;207-215.
11. Rowley J.D. Rearrangements involving chromosome band 11q23 in acute leukaemia. Sem. Cancer Biol. 4:1993;377-385.
12. Drexler H.G., MacLeod R.A.F., Borkhardt A., Janssen J.W.G. Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines. Leukemia. 9:1995;480-500.
13. Shurtleff S.A., Buijs A., Behm F.G., Rubnitz J.E., Raimondi S.C., Hancock M.L., Chan G.C.-F., Pui C.-H., Grosveld G., Downing J.R. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia. 9:1995;1985-1989.
14. Andersson B.S., Collins V.P., Kurzrock R., Larkin D.W., Childs C., Ost A., Cork A., Trujillo J.M., Freireich E.J. KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts. Leukemia. 9:1995;2100-2108.
15. Hamaguchi H., Suzukawa K., Nagata K., Yamamoto K., Yagasaki F., Morishita K. Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome. Br. J. Haematol. 98:1997;399-407.
16. Van Rhee F., Hochhaus A., Lin F., Melo J.V., Goldman J.M., Cross N.C.P. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood. 87:1996;5213-5217.
17. Okamura J., Yamada S., Ishii E., Hara T., Takahira H., Nishimura J., Yumura K., Kawa-Ha K., Takase K., Enomoto Y., Tasaka H. A novel leukemia cell line, MR-87 with positive Philadelphia chromosome and negative breakpoint cluster region rearrangement coexpressing myeloid and early B-cell markers. Blood. 72:1988;1262-1268.
18. Wada H., Mizutani S., Nishimura J., Usuki Y., Kohsaki M., Komai M., Kaneko H., Sakamoto S., Delia D., Kanamaru A., Kakishita E. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein. Cancer Res. 55:1995;3192-3196.